US 8802689
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
granted A61KA61K31/4439A61K9/48
Quick answer
US patent 8802689 (Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases) held by The Regents of the University of California expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4439, A61K9/48, A61P, A61P13/08